Champions Oncology (CSBR) SEC Filings: History & Chart

Champions Oncology, Inc.(CSBR)

Biotechnology · Hackensack, NJ

$5.01+0.04 (+0.80%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Champions Oncology, Inc.

Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice. Utilizing this proprietary platform, the company not only delivers personalized cancer solutions directly but also provides Translational Oncology Solutions, supporting pharmaceutical and biotechnology companies through their drug development lifecycle. Additionally, Champions Oncology offers Lumin Bioinformatics, a comprehensive software platform and data tool filled with insights from research services and clinical studies, accessible through annual subscriptions. The company distributes its offerings through various channels, including online platforms, word-of-mouth referrals, and a dedicated sales team, reaching both patients and healthcare professionals. Established in 1985, Champions Oncology, Inc. is based in Hackensack, New Jersey, and was formerly known as Champions Biotechnology, Inc. until its name change in April 2011.

Hackensack, NJ

214 employees

www.championsoncology.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Robert Brainin

View full financials

Form	Filing Date	Accepted	Document
10-Q	Sep 11, 2026	Sep 11, 2026	View filing
8-K	Sep 10, 2026	Sep 10, 2026	View filing
DEFA14A	Aug 28, 2026	Aug 28, 2026	View filing
DEF 14A	Aug 28, 2026	Aug 28, 2026	View filing
10-K	Jul 27, 2026	Jul 27, 2026	View filing
8-K	Jul 27, 2026	Jul 27, 2026	View filing
8-K	Mar 30, 2026	Mar 30, 2026	View filing
10-Q	Mar 12, 2026	Mar 12, 2026	View filing
8-K	Mar 12, 2026	Mar 12, 2026	View filing
4	Jan 30, 2026	Jan 30, 2026	View filing
4	Jan 30, 2026	Jan 30, 2026	View filing
3	Jan 16, 2026	Jan 16, 2026	View filing
10-Q	Dec 15, 2025	Dec 15, 2025	View filing
8-K	Dec 15, 2025	Dec 15, 2025	View filing
4	Nov 7, 2025	Nov 7, 2025	View filing
4	Nov 7, 2025	Nov 7, 2025	View filing
4	Nov 7, 2025	Nov 7, 2025	View filing
4	Nov 7, 2025	Nov 7, 2025	View filing
4	Nov 7, 2025	Nov 7, 2025	View filing
4	Nov 6, 2025	Nov 6, 2025	View filing
8-K	Oct 16, 2025	Oct 16, 2025	View filing
10-Q	Sep 15, 2025	Sep 15, 2025	View filing
8-K	Sep 15, 2025	Sep 15, 2025	View filing
DEFA14A	Aug 22, 2025	Aug 22, 2025	View filing
DEF 14A	Aug 22, 2025	Aug 22, 2025	View filing
10-K	Jul 23, 2025	Jul 23, 2025	View filing
8-K	Jul 23, 2025	Jul 23, 2025	View filing
8-K	Jul 21, 2025	Jul 21, 2025	View filing
4	Apr 2, 2025	Apr 2, 2025	View filing
10-Q	Mar 17, 2025	Mar 17, 2025	View filing

SEC Filings

Recent Filings